A single site, open label study to evaluate the pharmacodynamic effects of a single dose of oral anatabine citrate in healthy adult volunteers.

Trial Profile

A single site, open label study to evaluate the pharmacodynamic effects of a single dose of oral anatabine citrate in healthy adult volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Anatabine (Primary)
  • Indications Alzheimer's disease; Inflammation; Smoking withdrawal; Thyroiditis
  • Focus Pharmacodynamics; Proof of concept
  • Sponsors Zenith Technology Corporation
  • Most Recent Events

    • 01 Jul 2015 Results published in a Rock Creek Pharmaceuticals media release.
    • 19 Mar 2015 Status changed from active, no longer recruiting to completed, as reported by Australian New Zealand Clinical Trials Registry.
    • 12 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top